Zosano Pharma Corporation

128 articles about Zosano Pharma Corporation

• Zosano Pharma, Inc. And Eli Lilly Enter Into Exclusive Licensing Agreement For Zosano's ZP-PTH Product Candidate

  12/2/2014

• Adhesive Patch Biotech Zosano Pharma, Inc. Postpones $70 Million IPO

  8/27/2014

• Johnson & Johnson Spinout Zosano Pharma, Inc. Sets Terms For $70 Million IPO

  7/18/2014

• Zosano Pharma, Inc. Appoints Troy Wilson, Ph.D., J.D., To Board Of Directors

  6/25/2014

• Zosano Pharma, Inc. Files Registration Statement For Proposed Initial Public Offering

  6/24/2014

• Zosano Pharma, Inc. To Present At The 74th American Diabetes Association Scientific Session

  6/16/2014

• Zosano Pharma, Inc. Appoints Winnie W. Tso, CPA As Chief Financial Officer

  6/2/2014

• Zosano Pharma, Inc. To Present At The 3rd International Microneedle Conference

  5/19/2014

• Zosano Pharma, Inc. Strikes $115 Million+ Drug Delivery Pact With Novo Nordisk A/S

  2/5/2014

• Zosano Pharma, Inc. Appoints Nandan Oza as Chief Operations Officer

  5/14/2013

• Zosano Pharma, Inc. Expands Board of Directors with Addition of Kleanthis G. Xanthopoulos, Ph.D.

  4/15/2013

• Zosano Pharma, Inc. Announces Key Strategic Hire

  4/9/2013

• Zosano Pharma, Inc. and Asahi Kasei Pharma Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone(TM) (teriparatide acetate)

  10/10/2011

• Zosano Pharma, Inc. to Present at the 14th Annual Drug Delivery Partnerships Meeting

  1/20/2010

• Zosano Pharma, Inc. Announces Publication of Positive Phase 2 Study of Its ZP-PTH Patch for Osteoporosis Therapy

  11/9/2009

• Zosano Pharma, Inc. to Provide Pipeline Updates at the 2009 AAPS Annual Meeting

  11/2/2009

• Zosano Pharma, Inc. Secures $30 Million in New Round of Financing

  7/8/2009

• Zosano Pharma, Inc. Announces Appointment of Thorsten von Stein as Chief Medical Officer

  6/11/2009

• Zosano Pharma, Inc. Presents Positive Phase 2 Results of Its Needle-Free Osteoporosis Therapy

  4/6/2009

• Zosano Pharma, Inc. to Present Positive Phase 2 Results of Its Transdermal Patch for Osteoporosis

  3/31/2009